Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04169347
Title FOLFOXIRI Plus Panitumumab in Metastatic RAS Wild-type, Left-sided Colorectal Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Criterium, Inc.
Indications

rectum adenocarcinoma

colon adenocarcinoma

Therapies

Fluorouracil + Irinotecan + Leucovorin + Oxaliplatin + Panitumumab

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST